Amarin | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AbbVie USD 5.52B 1.73B 2024-12
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amarin USD 156.94M 58.98M 2024-09
AstraZeneca USD 5.23B 258M 2025-03
DBV Technologies USD 32.5M 4.51M 2024-12
GlaxoSmithKline GBP 4.46B 594M 2025-03
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 8.87B 4.74B 2024-12



Amarin Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.